| Stage | SOLS | % of rev | ECVT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.0B | 100.00% | $250M | 100.00% | SOLS ×4.18 |
| Gross profit | $345M | 32.98% | $50M | 19.94% | SOLS +13.0pp |
| Operating income | $164M | 15.68% | $19M | 7.75% | SOLS +7.9pp |
| Pre-tax income | $112M | 10.71% | $15M | 5.96% | SOLS +4.8pp |
| Net income | $88M | 8.41% | $8M | 3.15% | SOLS +5.3pp |
| Stage | SOLS | ECVT | Gap · A − B |
|---|---|---|---|
| Revenue | $1.0B100.00% | $250M100.00% | SOLS ×4.18 |
| Gross profit | 32.98%$345M | 19.94%$50M | SOLS +13.0pp |
| Operating income | 15.68%$164M | 7.75%$19M | SOLS +7.9pp |
| Pre-tax income | 10.71%$112M | 5.96%$15M | SOLS +4.8pp |
| Net income |
| 8.41%$88M |
| 3.15%$8M |
| SOLS +5.3pp |
No shared counterparties.